SYNLOGIC, INC. Investment Income, Nonoperating
SYNLOGIC, INC. (SYBX) reported Investment Income, Nonoperating of $120.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2026-08-11
- SYNLOGIC, INC. investment income, nonoperating for the quarter ending 2026-06-30 was $120.00K, a 33.70% decline year-over-year.
- SYNLOGIC, INC. investment income, nonoperating for the quarter ending 2026-03-31 was $128.00K, a 31.91% decline year-over-year.
- SYNLOGIC, INC. investment income, nonoperating for the quarter ending 2025-12-31 was $151.00K, a 32.59% decline year-over-year.
- SYNLOGIC, INC. investment income, nonoperating for the quarter ending 2025-09-30 was $175.00K, a 31.10% decline year-over-year.
- SYNLOGIC, INC. investment income, nonoperating for fiscal 2025 was $695.00K, a 51.23% decline from fiscal 2024.
- SYNLOGIC, INC. investment income, nonoperating for fiscal 2024 was $1.43M, a 42.28% decline from fiscal 2023.
- SYNLOGIC, INC. investment income, nonoperating for fiscal 2023 was $2.47M, a 94.87% increase from fiscal 2022.
- SYNLOGIC, INC. investment income, nonoperating for fiscal 2022 was $1.27M, a 503.33% increase from fiscal 2021.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 6 month | Investment Income, Nonoperating 9 month | Investment Income, Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $120.00K 10-Q · filed 2026-08-11 | $248.00K 10-Q · filed 2026-08-11 | $399.00K derived: sum of 3 quarters · filed 2026-08-11 | $574.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $128.00K 10-Q · filed 2026-05-14 | $279.00K derived: sum of 2 quarters · filed 2026-05-14 | $454.00K derived: sum of 3 quarters · filed 2026-05-14 | $635.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $151.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $326.00K derived: sum of 2 quarters · filed 2026-03-12 | $507.00K derived: sum of 3 quarters · filed 2026-08-11 | $695.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $175.00K 10-Q · filed 2025-11-13 | $356.00K derived: sum of 2 quarters · filed 2026-08-11 | $544.00K 10-Q · filed 2025-11-13 | $768.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $181.00K 10-Q · filed 2026-08-11 | $369.00K 10-Q · filed 2026-08-11 | $593.00K derived: sum of 3 quarters · filed 2026-08-11 | $847.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $188.00K 10-Q · filed 2026-05-14 | $412.00K derived: sum of 2 quarters · filed 2026-05-14 | $666.00K derived: sum of 3 quarters · filed 2026-05-14 | $1.06M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $478.00K derived: sum of 2 quarters · filed 2026-03-12 | $872.00K derived: sum of 3 quarters · filed 2026-03-12 | $1.43M 10-K · filed 2026-03-12 |
| 2024-09-30 | $254.00K 10-Q · filed 2025-11-13 | $648.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.20M 10-Q · filed 2025-11-13 | $1.88M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $394.00K 10-Q · filed 2025-08-07 | $947.00K 10-Q · filed 2025-08-07 | $1.62M derived: sum of 3 quarters · filed 2025-08-07 | $2.17M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $553.00K 10-Q · filed 2025-05-08 | $1.23M derived: sum of 2 quarters · filed 2025-05-08 | $1.78M derived: sum of 3 quarters · filed 2025-05-08 | $2.39M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $675.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $1.22M derived: sum of 2 quarters · filed 2025-03-06 | $1.84M derived: sum of 3 quarters · filed 2025-03-06 | $2.47M 10-K · filed 2025-03-06 |
| 2023-09-30 | $549.00K 10-Q · filed 2024-11-12 | $1.17M derived: sum of 2 quarters · filed 2024-11-12 | $1.79M 10-Q · filed 2024-11-12 | $2.40M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $617.00K 10-Q · filed 2024-08-08 | $1.25M 10-Q · filed 2024-08-08 | $1.85M derived: sum of 3 quarters · filed 2024-08-08 | $2.28M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $628.00K 10-Q · filed 2024-05-14 | $1.24M derived: sum of 2 quarters · filed 2024-05-14 | $1.66M derived: sum of 3 quarters · filed 2024-05-14 | $1.83M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $609.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $1.03M derived: sum of 2 quarters · filed 2024-03-19 | $1.20M derived: sum of 3 quarters · filed 2024-03-19 | $1.27M 10-K · filed 2024-03-19 |
| 2022-09-30 | $422.00K 10-Q · filed 2023-11-09 | $591.00K derived: sum of 2 quarters · filed 2023-11-09 | $658.00K 10-Q · filed 2023-11-09 | $717.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $169.00K 10-Q · filed 2023-08-10 | $236.00K 10-Q · filed 2023-08-10 | $295.00K derived: sum of 3 quarters · filed 2023-08-10 | $336.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $67.00K 10-Q · filed 2023-05-11 | $126.00K derived: sum of 2 quarters · filed 2023-05-11 | $167.00K derived: sum of 3 quarters · filed 2023-05-11 | $217.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $100.00K derived: sum of 2 quarters · filed 2023-03-29 | $150.00K derived: sum of 3 quarters · filed 2023-03-29 | $210.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $41.00K 10-Q · filed 2022-11-10 | $91.00K derived: sum of 2 quarters · filed 2022-11-10 | $151.00K 10-Q · filed 2022-11-10 | $257.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $50.00K 10-Q · filed 2022-08-11 | $110.00K 10-Q · filed 2022-08-11 | $216.00K derived: sum of 3 quarters · filed 2022-08-11 | $432.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $60.00K 10-Q · filed 2022-05-12 | $166.00K derived: sum of 2 quarters · filed 2022-05-12 | $382.00K derived: sum of 3 quarters · filed 2022-05-12 | $788.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $322.00K derived: sum of 2 quarters · filed 2022-03-17 | $728.00K derived: sum of 3 quarters · filed 2022-03-17 | $1.30M 10-K · filed 2022-03-17 |
| 2020-09-30 | $216.00K 10-Q · filed 2021-11-10 | $622.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.20M 10-Q · filed 2021-11-10 | $1.89M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $406.00K 10-Q · filed 2021-08-12 | $980.00K 10-Q · filed 2021-08-12 | $1.67M derived: sum of 3 quarters · filed 2021-08-12 | $2.53M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $574.00K 10-Q · filed 2021-05-13 | $1.26M derived: sum of 2 quarters · filed 2021-05-13 | $2.12M derived: sum of 3 quarters · filed 2021-05-13 | $2.88M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $689.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.55M derived: sum of 2 quarters · filed 2021-03-25 | $2.31M derived: sum of 3 quarters · filed 2021-03-25 | $3.06M 10-K · filed 2021-03-25 |
| 2019-09-30 | $857.00K 10-Q · filed 2020-11-05 | $1.62M derived: sum of 2 quarters · filed 2020-11-05 | $2.37M 10-Q · filed 2020-11-05 | $3.16M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $759.00K 10-Q · filed 2020-08-06 | $1.52M 10-Q · filed 2020-08-06 | $2.30M derived: sum of 3 quarters · filed 2020-08-06 | $3.10M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $757.00K 10-Q · filed 2020-05-08 | $1.54M derived: sum of 2 quarters · filed 2020-05-08 | $2.34M derived: sum of 3 quarters · filed 2020-05-08 | $3.11M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $784.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.58M derived: sum of 2 quarters · filed 2020-03-12 | $2.36M derived: sum of 3 quarters · filed 2020-03-12 | $2.84M 10-K · filed 2020-03-12 |
| 2018-09-30 | $797.00K 10-Q · filed 2019-11-12 | $1.57M derived: sum of 2 quarters · filed 2019-11-12 | $2.06M 10-Q · filed 2019-11-12 | $2.30M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $776.00K 10-Q · filed 2019-08-08 | $1.26M 10-Q · filed 2019-08-08 | $1.50M derived: sum of 3 quarters · filed 2019-08-08 | $1.67M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $486.00K 10-Q · filed 2019-05-09 | $723.00K derived: sum of 2 quarters · filed 2019-05-09 | $893.00K derived: sum of 3 quarters · filed 2019-05-09 | $974.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $407.00K derived: sum of 2 quarters · filed 2019-03-12 | $488.00K derived: sum of 3 quarters · filed 2019-03-12 | $504.00K 10-K · filed 2019-03-12 |
| 2017-09-30 | $170.00K 10-Q · filed 2018-11-13 | $251.00K derived: sum of 2 quarters · filed 2018-11-13 | $267.00K 10-Q · filed 2018-11-13 | $281.00K derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $81.00K 10-Q · filed 2018-08-09 | $97.00K 10-Q · filed 2018-08-09 | $111.00K derived: sum of 3 quarters · filed 2018-08-09 | $114.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $16.00K 10-Q · filed 2018-05-15 | $30.00K derived: sum of 2 quarters · filed 2018-05-15 | $33.00K derived: sum of 3 quarters · filed 2018-05-15 | |
| 2016-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $17.00K derived: sum of 2 quarters · filed 2018-03-20 | $17.00K 10-K · filed 2018-03-20 | |
| 2016-09-30 | $3.00K 10-Q · filed 2017-11-13 | $3.00K 10-Q · filed 2017-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |